Copyright
©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Jan 28, 2005; 11(4): 538-544
Published online Jan 28, 2005. doi: 10.3748/wjg.v11.i4.538
Published online Jan 28, 2005. doi: 10.3748/wjg.v11.i4.538
Table 2 Histological scoring (action of PACAP) (mean±SE).
Group | Hemorrhage | Parenchymal necrosis | Vacuolization | Inflammation |
Caerulein-induced pancreatitis | 1.67±0.60 | 2.5±0.22 | ||
Sodium taurocholate-induced pancreatitis | 1.5±0.67 | 2.5±0.49 | 0.5±0.49 | 3 |
PACAP 5 μg | 0.33±0.33 | 0.17±0.17 | ||
PACAP 10 μg | 0.17±0.17 | 0.67±0.49 | 1.33±0.61 | |
PACAP 15 μg | 0.33±0.33 | 1.5±0.67 | ||
PACAP 30 μg | 0.17±0.17 | 0.83±0.54 | 1.5±0.5 | |
Sodium taurocholate+PACAP 5 μg | 1.67±0.49 | 2.67±0.33 | 2±0.63 | 3 |
Sodium taurocholate +PACAP 10 μg | 2±0.63 | 2.5±0.5 | 1.5±0.56 | 3 |
Caerulein+PACAP 15 μg | 1.5±0.5 | 2±0.63 | 2.5±0.22 | 1.67±0.60 |
Caerulein+PACAP 30 μg | 1.83±0.60 | 2.17±0.31 | 2.33±0.49 | 2.17±0.48 |
- Citation: Chen YD, Zhou ZG, Wang Z, Gao HK, Yan WW, Wang C, Zhao GP, Peng XH. Pituitary adenylate cyclase activating-peptide and its receptor antagonists in development of acute pancreatitis in rats. World J Gastroenterol 2005; 11(4): 538-544
- URL: https://www.wjgnet.com/1007-9327/full/v11/i4/538.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i4.538